Could There Be an Alternative Explanation for Cardiomyopathy in an Infant Following Fosphenytoin Overdose?

Abstract

Get full access to this article

View all access options for this article.

References

Grageda

Saini

Trout

Cyran

Halstead

. Severe cardiomyopathy in an infant after iatrogenic fosphenytoin overdose [published online October 21, 2013]. Clin Pediatr (Phila). doi:10.1177/0009922813505698.

Browne

Kugler

Eldon

. Pharmacology and pharmacokinetics of fosphenytoin. Neurology. 1996;46(6 suppl 1):3S-7S.

McBryde

Wilcox

Kher

. Hyperphosphatemia due to fosphenytoin in a pediatric ESRD patient. Pediatr Nephrol. 2005;20:1182-1185.

Keegan

Bondy

Blackshear

Lanier

. Hypocalcemia-like electrocardiographic changes after administration of intravenous fosphenytoin. Mayo Clin Proc. 2002;77:584-586.

Gupta

Tomar

Radhakrishnan

Shrivastava

. Hypocalcemic cardiomyopathy presenting as cardiogenic shock. Ann Pediatr Cardiol. 2011;4:152-155.